Medications

FDA approves biosimilar ogivri for breast, stomach cancers

(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.

Medical research

Where cigarette smoking's damage is done... down to your DNA

Scientists have known for decades that smoking cigarettes causes DNA damage, which leads to lung cancer. Now, for the first time, UNC School of Medicine scientists created a method for effectively mapping that DNA damage ...

HIV & AIDS

Study reveals how HIV virus destroys lung tissue

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop the chronic lung disease emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that ...

Diseases, Conditions, Syndromes

Study shows potential of stem cell therapy to repair lung damage

A new study has found that stem cell therapy can reduce lung inflammation in an animal model of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Although, still at a pre-clinical stage, these findings have ...

Diseases, Conditions, Syndromes

Mechanical ventilation as aggravating factor in lung failure

Mechanical ventilation can contribute to lung damage by inducing rapid changes in oxygen levels. Researchers at the Medical University of Vienna are now conducting studies for the first time into the significance of these ...

page 2 from 10